Clinical Trial Update: Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/3 trial evaluated Vitamin D (cholecalciferol) for preserving residual beta-cell function in Type 1 diabetes. Results were posted July 10, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Benjamin U. Nwosu, MD | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-07-10